CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (4,007,777)	$ (2,922,063)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	120,469	120,469
Depreciation	30,853	0
Stock-based compensation and warrants	283,205	327,118
(Increase) decrease in assets
Prepaid drug product for testing	(249,711)	(45,199)
Other current assets	(100,279)	(130,064)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	(80,742)	(11,740)
Net cash used in operating activities	(4,003,982)	(2,661,479)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase furniture, fixtures & equipment	0	(66,124)
Net cash used in investing activities	0	(66,124)
CASH FLOW FROM FINANCING ACTIVITIES
Net proceeds from sale of common stock	0	13,812,373
Net cash from financing activities	0	13,812,373
NET INCREASE (DECREASE) IN CASH	(4,003,982)	11,084,770
Cash, beginning of period	13,858,798	3,551,832
Cash, end of period	$ 9,854,816	$ 14,636,602